Test-And-Prevent Analysis: Key findings

test and prevent

OPTIONS Consortium

Significant resources have created strong ‘test and treat’ programs globally. What about those who test HIV negative? How can we strengthen linkage of HIV-negative individuals to prevention programs in ways that work for them? In our recently completed Test-And-Prevent Analysis, the OPTIONS Consortium identifies practices for linking individuals from HIV testing to HIV prevention. This work aims to identify interventions that are effective, the enabling conditions that support linkage, and remaining questions.

May 23, 2019
Year of publication
Resource types
Briefs, Reports and Fact sheets
test-and-treat, test-and-prevent, HIV prevention, HIV testing

Similar Resources

For people who may have been exposed to HIV, knowledge is critical to making informed decisions about their future. An HIV test is a serious event with potentially serious outcomes. But no matter the result, the test provides vital information.

Timely access to antiretroviral treatment (ART) is vital to ensuring safe motherhood and reducing vertical transmission. Treatment guidance and programming has changed dramatically in recent years.

Remarkable progress is being made on HIV treatment. Ahead of World AIDS Day, UNAIDS has launched a new report showing that access to treatment has risen significantly. In 2000, just 685 000 people living with HIV had access to antiretroviral therapy.

The 2018 International AIDS Conference called attention to men’s low uptake of HIV testing services (HTS) and the need for greater efforts to ensure men know their status and link to treatment if they test positive for HIV.

The Southern African HIV Clinicians Society’s biannual conference, held in Johannesburg, South Africa, from 24-27 October 2018, focused on clinical content for HIV and TB health care workers in the region and featured a wide range of topics…

This brief provides clear and concise detail about various testing strategies which can be used to ensure efficient case-finding, including index testing, risk network referral, and the enhanced peer outreach approach.

The expanded availability of antiretroviral medicines and their beneficial effect in suppressing the viral loads of people living with HIV is contributing to a reduction in new HIV infections. However, on its own this is not enough.

Despite numerous international treaties and commitments to protect the health rights of migrants, this population still faces significant barriers in their access to TB care.

mHealth is the use of mobile and wireless technologies to support the achievement of health objectives.

The prison setting presents not only challenges, but also opportunities, for the prevention and treatment of HIV, viral hepatitis, and tuberculosis.